Hepatitis Foundation of New Zealand

Hepatitis Foundation of New Zealand Hepatitis help, care and support
Hepatitis B āwhina tiaki me te tautoko In 1984, the newly established foundation implemented the Kawerau Seroprevalence Study.

The Hepatitis Foundation of New Zealand has completed many major screening, vaccination and research programmes in New Zealand, the Pacific Islands and Vietnam during its 30-year history. This saw 93 percent of Kawerau’s population tested for hepatitis B. The results showed the virus was highly endemic. Nine years later, as a result of the foundation’s work, NZ was the first sovereign nation to introduce universal hepatitis B vaccinations for all children. From 1999 - 2002 the largest national hepatitis B screening programme ever conducted took place in NZ. A total of 177,292 New Zealanders were screened, with 11,936 people identified as having chronic hepatitis B. The early 2000s saw the establishment of the free national long-term monitoring programme at the foundation. The programme continues today, successfully following up and monitoring more than 24,000 people with chronic hepatitis B. For further information please call our free helpline: 0800 33 20 10.

🚨 Is the Hepatitis B Vaccine Safe? What You Need to Know. 🚨Following recent international discussions, the Hepatitis Fou...
03/10/2025

🚨 Is the Hepatitis B Vaccine Safe? What You Need to Know. 🚨

Following recent international discussions, the Hepatitis Foundation of New Zealand is speaking out to reaffirm the critical importance and safety of our national hepatitis B vaccination schedule! 🛡️

Here in Aotearoa, the vaccine has been a cornerstone of public health for over 35 years—and for good reason:

94,000 Kiwis are currently impacted by this dangerous, cancer-causing virus.

The vaccine is the best prevention against chronic liver disease, cirrhosis, and liver cancer.

For babies born to mothers with Hepatitis B, the vaccine within 24 hours of birth is 90% crucial for preventing a lifelong chronic illness.

Professor Ed Gane, Specialist Hepatologist, confirms: "The Hepatitis B vaccine is a crucial investment in the long-term health and prosperity of all New Zealanders."

It’s more than just an injection; it’s a powerful tool for protecting our most vulnerable.

Want the facts about New Zealand's world-leading vaccination program and how it protects your whānau?

👉 Click to read the Foundation's full statement and find out who is eligible for the free vaccine: https://www.hepatitisfoundation.org.nz/blog/post/153427/critical-importance-of-hepatitis-b-vaccine/

Following international reports and political commentary questioning the efficacy and safety of the hepatitis B vaccine, the Hepatitis Foundation of New Zealand today reaffirmed its unwavering support

Health professionals, this one is for you - come along to our Webinar on October 8th - Healthy livers: Understanding the...
19/09/2025

Health professionals, this one is for you - come along to our Webinar on October 8th - Healthy livers: Understanding the causes and how to reduce the risk of liver cancer.

Over 400 New Zealanders are diagnosed with primary liver cancer (hepatocellular carcinoma, HCC), each year. This cancer disproportionately impacts Maori, Pasifika, and Asian communities, as hepatitis B is the main cause. 94,000 people in Aotearoa are living with hepatitis B (HBV), and almost half are undiagnosed. Along with hepatitis B, metabolic-associated steatotic liver disease (MASLD, formally known as NAFLD), alcohol use and hepatitis C are the other main risk factors for liver cancer in Aotearoa.

This webinar will provide an overview of the key risk factors for liver cancer along with liver assessment in primary care, important advice for optimising liver health, liver cancer risk reduction, monitoring and early detection.

Presented by Dr. Alex Lampen-Smith, a Gastroenterologist and Hepatologist at Hauora a Toi Bay of Plenty and Specialist Hepatologist for the Hepatitis Foundation of NZ, will guide our discussion.

Join us Wednesday, October 8 - 7-8pm for this evening webinar to learn how you can better support your patients.

REGISTRATIONS REQUIRED
Use the link: https://lnkd.in/g6ggsJ53

29/07/2025
28/07/2025
Hepatitis is one of the world's most common infectious diseases, with over 250 million people globally living with chron...
27/07/2025

Hepatitis is one of the world's most common infectious diseases, with over 250 million people globally living with chronic Hepatitis B virus (HBV).

Right here in New Zealand, an estimated 94,000 people are living with HBV, and alarmingly, 50% of these are yet to be diagnosed. HBV is the primary cause of primary liver cancer in NZ, contributing to an estimated 300 deaths annually due to hepatitis B and C.

At The Hepatitis Foundation, we run a free, lifelong, national monitoring program for all New Zealanders living with HBV, which is proven to improve health outcomes. People registered with HFNZ receive regular HBV monitoring, assessment, education, and support.

If you or your whānau would like to be tested or need support, we're here for you. Contact our free nationwide helpline on 0800 33 20 10 or email us at hepteam@hfnz.nz for all enquiries.

Could you have hepatitis B? If you can answer ‘Yes’ to any of the below you are more at risk of having contracted hepati...
26/07/2025

Could you have hepatitis B? If you can answer ‘Yes’ to any of the below you are more at risk of having contracted hepatitis B:

✔ You are over 35 years of age
✔ You are of Māori, Pacific or Asian ethnicity
✔ Your mother or close family member has hepatitis B
✔ You live with someone who has hepatitis B
✔ You were born outside New Zealand, from a high risk country
✔ Have had unprotected sex with a person living with hepatitis B
✔ Have ever injected drugs
✔ Have received a tattoo using unsterilised equipment

We can check through a blood test. Let’s get you tested today, you can call 0800 33 20 10 or ask your GP for a blood test.

24/07/2025

Over 94,000 people in New Zealand are living with chronic hepatitis, with many unaware of their status. Hepatitis is the leading cause of liver cancer.

Here at the Hepatitis Foundation, we drive early detection by encouraging testing and by providing ongoing support through our national free monitoring programme.

If you think you are at risk or have it, give us a call on 0800 33 20 10 to get a free blood test.

Exciting news for public health in Aotearoa, New Zealand. The Hepatitis Foundation of New Zealand (HFNZ) and GSK New Zea...
24/07/2025

Exciting news for public health in Aotearoa, New Zealand. The Hepatitis Foundation of New Zealand (HFNZ) and GSK New Zealand Limited (GSK) have joined forces to eliminate hepatitis B in Aotearoa.

This partnership combines HFNZ's vital, free, lifelong monitoring program for New Zealanders with chronic hepatitis B (CHB) and GSK's leading role in hepatitis B prevention through vaccines and treatment research.

Together, we're committed to advancing health outcomes for people with hepatitis B, strengthening New Zealand’s response to the disease, improving health equity for all, and contributing to the global goal of hepatitis B elimination.

This collaboration marks a significant milestone in our journey towards a hepatitis B-free New Zealand. Stay tuned for updates on our progress.

Pictured: Brett Marett - Country Medical Director, GSK New Zealand, Rainger, Board Chair, Hepatitis Foundation of NZ, Sarah Davey, CEO, Hepatitis Foundation of NZ, Teresa Chen-Christman - Medical Affairs Manager, HIV and Specialty, GSK NZ, Jasmine Jurd - Specialty Business Head, GSK New Zealand, Professor Edward Gane, Specialist Hepatologist and Board Member, Hepatitis Foundation of NZ

hashtag hashtag hashtag hashtag hashtag hashtag

Address

61 Alexander Avenue
Whakatane
3120

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Telephone

+6473071259

Alerts

Be the first to know and let us send you an email when Hepatitis Foundation of New Zealand posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Hepatitis Foundation of New Zealand has completed many major screening, vaccination and research programmes in New Zealand, the Pacific Islands and Vietnam during its 30-year history. In 1984, the newly established foundation implemented the Kawerau Seroprevalence Study. It tested 93 percent of Kawerau’s population for hepatitis B. The results showed the virus was highly endemic. Nine years later, as a result of the foundation’s work, New Zealand was the first sovereign nation to introduce universal hepatitis B vaccination for all children. From 1999-2002 the largest national hepatitis B screening programme ever conducted took place in New Zealand. A total of 177,292 New Zealanders were screened, with 11,936 people with chronic hepatitis B identified. In the early 2000s the foundation launched its free national long-term monitoring programme. This continues today, successfully following up and monitoring about 25,000 people with chronic hepatitis B.